Novel mechanistic insights into viral modulation of immune receptor signaling

PLoS Pathogens

Volumn 5, Issue 7, 2009, Pages

  Sigalov, Alexander B ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR; GLYCOPROTEIN GP 41; GP41 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOGLOBULIN RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

ANTIGEN RECOGNITION; IMMUNE RESPONSE; IMMUNOMODULATION; MEMBRANE POTENTIAL; NONHUMAN; NOTE; NUCLEOTIDE SEQUENCE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; VIRUS; AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BIOLOGICAL MODEL; HUMAN; IMMUNOLOGY; MOLECULAR GENETICS; MOUSE; PATHOGENICITY;

AMINO ACID SEQUENCE; ANIMALS; HIV ENVELOPE PROTEIN GP41; HUMANS; MICE; MODELS, IMMUNOLOGICAL; MOLECULAR SEQUENCE DATA; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; VIRUSES;

EID: 70049097909     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000404     Document Type: Note

References (52)

1. Biassoni R, Cantoni C, Falco M, Pende D, Millo R, et al. (2000) Human natural killer cell activating receptors. Mol Immunol 37: 1015-1024.
2. Manolios N, Bonifacino JS, Klausner RD (1990) Transmembrane helical interactions and the assembly of the T cell receptor complex. Science 249: 274-277. (Pubitemid 20232085)
3. Sigalov A (2005) Multi-chain immune recognition receptors: spatial organization and signal transduction. Semin Immunol 17: 51-64.
4. Sigalov A, Aivazian D, Stern L (2004) Homooligomerization of the cytoplasmic domain of the T cell receptor zeta chain and of other proteins containing the immunoreceptor tyrosine-based activation motif. Biochemistry 43: 2049-2061. (Pubitemid 38233267)
5. Sigalov AB, Zhuravleva AV, Orekhov VY (2007) Binding of intrinsically disordered proteins is not necessarily accompanied by a structural transition to a folded form. Biochimie 89: 419-421.
6. Sigalov AB (2004) Multichain immune recognition receptor signaling: different players, same game? Trends Immunol 25: 583-589.
7. Sigalov AB (2006) Immune cell signaling: a novel mechanistic model reveals new therapeutic targets. Trends Pharmacol Sci 27: 518-524.
8. Sigalov AB (2008) Signaling chain homooligomerization (SCHOOL) model. Adv Exp Med Biol 640: 121-163.
9. Loregian A, Palu G (2005) Disruption of protein-protein interactions: towards new targets for chemotherapy. J Cell Physiol 204: 750-762. (Pubitemid 41099260)
10. Sigalov AB (2007) Transmembrane interactions as immunotherapeutic targets: lessons from viral pathogenesis. Adv Exp Med Biol 601: 335-344.
11. Sigalov AB (2008) SCHOOL model and new targeting strategies. In: Sigalov AB, ed. Multichain Immune Recognition Receptor Signaling: From Spatiotemporal Organization to Human Disease. New York: Springer-Verlag New York Inc. pp 268-311.
12. Sigalov AB (2007) Interaction between HIV gp41 fusion peptide and T cell receptor: putting the puzzle pieces back together. Faseb J 21: 1633-1634; author reply 1635.
13. Kim WM, Sigalov AB (2008) Viral pathogenesis, modulation of immune receptor signaling and treatment. Adv Exp Med Biol 640: 325-349.
14. Jerome KR (2008) Viral modulation of T-cell receptor signaling. J Virol 82: 4194-4204.
15. Call ME, Pyrdol J , Wiedmann M, Wucherpfennig KW (2002) The organizing principle in the formation of the T cell receptor-CD3 complex. Cell 111: 967-979. (Pubitemid 36044689)
16. Manolios N, Collier S, Taylor J, Pollard J, Harrison LC, et al. (1997) T-cell antigen receptor transmembrane peptides modulate T-cell function and T cell-mediated disease. Nat Med 3: 84-88. (Pubitemid 27019147)
17. Enk AH, Knop J (2000) T cell receptor mimic peptides and their potential application in T-cell-mediated disease. Int Arch Allergy Immunol 123: 275-281.
18. Gollner GP, Muller G, Alt R, Knop J, Enk AH (2000) Therapeutic application of T cell receptor mimic peptides or cDNA in the treatment of T cell-mediated skin diseases. Gene Ther 7: 1000-1004. (Pubitemid 30398347)
19. Amon MA, Ali M, Bender V, Hall K, Aguilar MI, et al. (2008) Kinetic and conformational properties of a novel T-cell antigen receptor transmembrane peptide in model membranes. J Pept Sci 14: 714-724. (Pubitemid 351982716)
20. Kurosaka N, Ali M, Byth K, Manolios N (2007) The mode of anti-arthritic peptide delivery impacts on the severity and outcome of adjuvant induced arthritis. APLAR J Rheumatol 10: 198-203. (Pubitemid 47161759)
21. Kurosaka N, Bolte A, Ali M, Manolios N (2007) T-cell antigen receptor assembly and cell surface expression is not affected by treatment with T-cell antigen receptor-alpha chain transmembrane Peptide. Protein Pept Lett 14: 299-303. (Pubitemid 46376863)
22. Manolios N, Ali M, Amon M, Bender V (2008) Therapeutic application of transmembrane T and natural killer cell receptor peptides. Adv Exp Med Biol 640: 208-219.
23. Manolios N, Huynh NT, Collier S (2002) Peptides in the treatment of inflammatory skin disease. Australas J Dermatol 43: 226-227.
24. Wang XM, Djordjevic JT, Bender V, Manolios N (2002) T cell antigen receptor (TCR) transmembrane peptides colocalize with TCR, not lipid rafts, in surface membranes. Cell Immunol 215: 12-19. (Pubitemid 34936813)
25. Wang XM, Djordjevic JT, Kurosaka N, Schibeci S, Lee L, et al. (2002) T-cell antigen receptor peptides inhibit signal transduction within the membrane bilayer. Clin Immunol 105: 199-207. (Pubitemid 35471668)
26. Amon MA, Ali M, Bender V, Chan YN, Toth I, et al. (2006) Lipidation and glycosylation of a T cell antigen receptor (TCR) transmembrane hydrophobic peptide dramatically enhances in vitro and in vivo function. Biochim Biophys Acta. (Pubitemid 44209390)
27. Ali M, Amon M, Bender V, Manolios N (2005) Hydrophobic transmembrane-peptide lipid conjugations enhance membrane binding and functional activity in T-cells. Bioconjug Chem 16: 1556-1563. (Pubitemid 41681523)
28. Ali M, Salam NK, Amon M, Bender V, Hibbs DE, et al. (2006) T-Cell Antigen Receptor-alpha Chain Transmembrane Peptides: Correlation between Structure and Function. Int J Pept Res Ther 12: 261-267. (Pubitemid 44035105)
29. Quintana FJ, Gerber D, Kent SC, Cohen IR, Shai Y (2005) HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activation. J Clin Invest 115: 2149-2158. (Pubitemid 41134156)
30. Bloch I, Quintana FJ, Gerber D, Cohen T, Cohen IR, et al. (2007) T-Cell inactivation and immunosuppressive activity induced by HIV gp41 via novel interacting motif. Faseb J 21: 393-401. (Pubitemid 46213487)
31. Bosch ML, Earl PL, Fargnoli K, Picciafuoco S, Giombini F, et al. (1989) Identification of the fusion peptide of primate immunodeficiency viruses. Science 244: 694-697. (Pubitemid 19147680)
32. Gallaher WR (1987) Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus. Cell 50: 327-328.
33. van Praag RM, Prins JM, Roos MT, Schellekens PT, Ten Berge IJ, et al. (2001) OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletion. J Clin Immunol 21: 218-226. (Pubitemid 32434309)
34. Cianciolo GJ, Copeland TD, Oroszlan S, Snyderman R (1985) Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science 230: 453-455. (Pubitemid 16192559)
35. Ruegg CL, Monell CR, Strand M (1989) Identification, using synthetic peptides, of the minimum amino acid sequence from the retroviral transmembrane protein p15E required for inhibition of lymphoproliferation and its similarity to gp21 of human T-lymphotropic virus types I and II. J Virol 63: 3250-3256.
36. Ruegg CL, Monell CR, Strand M (1989) Inhibition of lymphoproliferation by a synthetic peptide with sequence identity to gp41 of human immunodeficiency virus type 1. J Virol 63: 3257-3260. (Pubitemid 19181381)
37. Yaddanapudi K, Palacios G, Towner JS, Chen I, Sariol CA, et al. (2006) Implication of a retrovirus-like glycoprotein peptide in the immunopathogenesis of Ebola and Marburg viruses. Faseb J 20: 2519-2530. (Pubitemid 44953824)
38. Arnon TI, Achdout H, Levi O, Markel G, Saleh N, et al. (2005) Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat Immunol 6: 515-523. (Pubitemid 41716765)
39. Sullivan BM, Coscoy L (2008) Downregulation of the T-cell receptor complex and impairment of T-cell activation by human herpesvirus 6 u24 protein. J Virol 82: 602-608.
40. Min CK, Bang SY, Cho BA, Choi YH, Yang JS, et al. (2008) Role of amphipathic helix of a herpesviral protein in membrane deformation and T cell receptor downregulation. PLoS Pathog 4: e1000209. doi:10.1371/journal.ppat. 1000209.
41. Park J, Lee BS, Choi JK, Means RE, Choe J, et al. (2002) Herpesviral protein targets a cellular WD repeat endosomal protein to downregulate T lymphocyte receptor expression. Immunity 17: 221-233. (Pubitemid 35245964)
42. Kikuta H, Lu H, Tomizawa K, Matsumoto S (1990) Enhancement of human herpesvirus 6 replication in adult human lymphocytes by monoclonal antibody to CD3. J Infect Dis 161: 1085-1087. (Pubitemid 20177864)
43. Roffman E, Frenkel N (1991) Replication of human herpesvirus-6 in thymocytes activated by anti-CD3 antibody. J Infect Dis 164: 617-618.
44. Melnyk RA, Partridge AW, Yip J, Wu Y, Goto NK, et al. (2003) Polar residue tagging of transmembrane peptides. Biopolymers 71: 675-685. (Pubitemid 38325778)
45. Smith SO, Smith C, Shekar S, Peersen O, Ziliox M, et al. (2002) Transmembrane interactions in the activation of the Neu receptor tyrosine kinase. Biochemistry 41: 9321-9332. (Pubitemid 34810006)
46. Cunningham F, Deber CM (2007) Optimizing synthesis and expression of transmembrane peptides and proteins. Methods 41: 370-380. (Pubitemid 46400520)
47. Yin H, Slusky JS, Berger BW, Walters RS, Vilaire G, et al. (2007) Computational design of peptides that target transmembrane helices. Science 315: 1817-1822. (Pubitemid 46580135)
48. Wimley WC, White SH (2000) Designing transmembrane alpha-helices that insert spontaneously. Biochemistry 39: 4432-4442.
49. Edwards RJ, Moran N, Devocelle M, Kiernan A, Meade G, et al. (2007) Bioinformatic discovery of novel bioactive peptides. Nat Chem Biol 3: 108-112. (Pubitemid 46134997)
50. Ashish, Wimley WC (2001) Visual detection of specific, native interactions between soluble and microbead-tethered alpha-helices from membrane proteins. Biochemistry 40: 13753-13759.
51. Killian JA (2003) Synthetic peptides as models for intrinsic membrane proteins. FEBS Lett 555: 134-138.
52. Collier S, Bolte A, Manolios N (2006) Discrepancy in CD3-transmembrane peptide activity between in vitro and in vivo T-cell inhibition. Scand J Immunol 64: 388-391. (Pubitemid 44408793)